Skip to content

Roivant Sciences Ltd.

ROIV Nasdaq SEC CIK 1635088

Follow Roivant Sciences Ltd. Weekly email: filings, results, news

News

6 stories filed under Roivant Sciences Ltd., grouped into ongoing threads

Transcript

Thread · 4 stories

Roivant Sciences Ltd. (ROIV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Markets 16 d ago also on WFC

Roivant Sciences Ltd. (ROIV) Discusses Top Line Results from PHocus Study of Mosliciguat in PH-ILD Transcript

Markets 16 d ago also on PH

Roivant Sciences Ltd. (ROIV) Discusses FDA Approval of LISRAYA as First Oral Targeted Therapy for Dermatomyositis Transcript

Markets 27 d ago

Roivant Sciences Ltd. (ROIV) Q1 2026 Earnings Call Transcript

Earnings 49 d ago

LISRAYA

Thread · 2 stories

What Lisraya’s $35,000 Monthly Price Could Mean for Roivant (ROIV)

Markets 17 d ago

Roivant Sciences Ltd. (ROIV) Discusses FDA Approval of LISRAYA as First Oral Targeted Therapy for Dermatomyositis - Slideshow

Markets 25 d ago

Next results

NOV5

Q1 2026 results

Thursday · estimated from the filing cadence

Profile

Headquarters: LONDON
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 6 stories clustered from the RSS aggregator